2025

Humphrey, T. J. L. et al. (2025) Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial. BMC Infectious Diseases, 25(1), 204. (doi: 10.1186/s12879-025-10584-4) (PMID:39934669) (PMCID:PMC11818026)

Collaborative Group, RECOVERY and (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Infectious Diseases, 25(9), pp. 1000-1010. (doi: 10.1016/S1473-3099(25)00093-3) (PMID:40383127)

Geddes, C. C. et al. (2025) Major complications of percutaneous native and transplant kidney biopsy: a complete 10-year national prospective cohort study. Clinical Kidney Journal, 18(7), sfaf196. (doi: 10.1093/ckj/sfaf196) (PMID:40661926) (PMCID:PMC12259278)

Collaborative Group, RECOVERY and (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81, 103080. (doi: 10.1016/j.eclinm.2025.103080) (PMID:40036152) (PMCID:PMC11872607)

2024

Kipgen, David, Crosby, Jana, Dey, Vishal, Kelly, Michael, McQuarrie, Emily and Geddes, Colin (2024) The relationship between histopathological features, immunosuppression and outcome in patients undergoing native kidney biopsies. Histopathology, (doi: 10.1111/his.15115) (PMID:38084646)

RECOVERY Collaborative Group, . (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Child and Adolescent Health, 8(3), pp. 190-200. (doi: 10.1016/s2352-4642(23)00316-4) (PMID:38272046)

2023

RECOVERY Collaborative Group (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Diabetes and Endocrinology, 11(12), pp. 905-914. (doi: 10.1016/s2213-8587(23)00253-x) (PMID:37865101) (PMCID:PMC10957483)

McGovern, D. P. et al. (2023) Outcomes in ANCA-associated vasculitis in Scotland: validation of the Renal Risk Score in a complete national cohort. Kidney International Reports, 8(8), pp. 1648-1656. (doi: 10.1016/j.ekir.2023.05.029) (PMID:37547534) (PMCID:PMC10403670)

RECOVERY Collaborative Group (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 401(10387), pp. 1499-1507. (doi: 10.1016/s0140-6736(23)00510-x) (PMID:37060915) (PMCID:PMC10156147)

Mayne, Kaitlin J., Lees, Jennifer S. ORCID: https://orcid.org/0000-0001-6331-0178, Rutherford, Elaine, Thomson, Peter C., Traynor, Jamie P., Dey, Vishal ORCID: https://orcid.org/0000-0002-5108-4158, Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887 and Mark, Patrick B. ORCID: https://orcid.org/0000-0003-3387-2123 (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16(3), pp. 512-520. (doi: 10.1093/ckj/sfac248) (PMID:36865003) (PMCID:PMC9972818)

RECOVERY Collaborative Group (2023) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 399(10320), pp. 143-151. (doi: 10.1016/s0140-6736(21)01825-0) (PMID:34800427) (PMCID:PMC8598213)

2022

RECOVERY Collaborative Group (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 399(10325), pp. 665-676. (doi: 10.1016/s0140-6736(22)00163-5) (PMID:35151397) (PMCID:PMC8830904)

2021

Aiyegbusi, O. et al. (2021) ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study. RMD Open, 7(2), e001555. (doi: 10.1136/rmdopen-2020-001555) (PMID:33875562) (PMCID:PMC8057563)

Abani, O. et al. (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet, 397(10289), pp. 2049-2059. (doi: 10.1016/S0140-6736(21)00897-7) (PMID:34000257) (PMCID:PMC8121538)

Abani, O. et al. (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10285), pp. 1637-1645. (doi: 10.1016/S0140-6736(21)00676-0) (PMID:33933206) (PMCID:PMC8084355)

RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine, 384(8), pp. 693-704. (doi: 10.1056/nejmoa2021436) (PMID:32678530) (PMCID:PMC7383595)

Abaleke, E. et al. (2021) Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10274), pp. 605-612. (doi: 10.1016/S0140-6736(21)00149-5) (PMID:33545096) (PMCID:PMC7884931)

Kolb, A. et al. (2021) A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney International Reports, 6(2), pp. 449-459. (doi: 10.1016/j.ekir.2020.10.033) (PMID:33615070) (PMCID:PMC7879209)

2020

RECOVERY Collaborative Group (2020) Effect of hydroxychloroquine in hospitalized patients with Covid-19. New England Journal of Medicine, 383(21), pp. 2030-2040. (doi: 10.1056/nejmoa2022926) (PMID:33031652) (PMCID:PMC7556338)

2017

Dey, Vishal ORCID: https://orcid.org/0000-0002-5108-4158, Farrah, Tariq E., Traynor, Jamie P., Spalding, Elaine M., Robertson, Susan E. and Geddes, Colin C. (2017) Symptomatic fracture risk in the renal replacement therapy population. Nephrology Dialysis Transplantation, 32(7), pp. 1211-1216. (doi: 10.1093/ndt/gfw222) (PMID:27257273)

2016

Dey, Vishal, Jones, Audrey and Spalding, Elaine M. (2016) Telehealth: acceptability, clinical interventions and quality of life in peritoneal dialysis. SAGE Open Medicine, 4, pp. 1-6. (doi: 10.1177/2050312116670188) (PMID:27757228) (PMCID:PMC5052928)

2015

Dey, V., Hair, M. and Spalding, E. M. (2015) Thrice weekly nocturnal in-centre haemodiafiltration: a 2-year experience. Nephron, 5, pp. 50-57. (doi: 10.1159/000436982) (PMID:26557842) (PMCID:PMC4592506)

Articles

Humphrey, T. J. L. et al. (2025) Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial. BMC Infectious Diseases, 25(1), 204. (doi: 10.1186/s12879-025-10584-4) (PMID:39934669) (PMCID:PMC11818026)

Collaborative Group, RECOVERY and (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Infectious Diseases, 25(9), pp. 1000-1010. (doi: 10.1016/S1473-3099(25)00093-3) (PMID:40383127)

Geddes, C. C. et al. (2025) Major complications of percutaneous native and transplant kidney biopsy: a complete 10-year national prospective cohort study. Clinical Kidney Journal, 18(7), sfaf196. (doi: 10.1093/ckj/sfaf196) (PMID:40661926) (PMCID:PMC12259278)

Collaborative Group, RECOVERY and (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81, 103080. (doi: 10.1016/j.eclinm.2025.103080) (PMID:40036152) (PMCID:PMC11872607)

Kipgen, David, Crosby, Jana, Dey, Vishal, Kelly, Michael, McQuarrie, Emily and Geddes, Colin (2024) The relationship between histopathological features, immunosuppression and outcome in patients undergoing native kidney biopsies. Histopathology, (doi: 10.1111/his.15115) (PMID:38084646)

RECOVERY Collaborative Group, . (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Child and Adolescent Health, 8(3), pp. 190-200. (doi: 10.1016/s2352-4642(23)00316-4) (PMID:38272046)

RECOVERY Collaborative Group (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Diabetes and Endocrinology, 11(12), pp. 905-914. (doi: 10.1016/s2213-8587(23)00253-x) (PMID:37865101) (PMCID:PMC10957483)

McGovern, D. P. et al. (2023) Outcomes in ANCA-associated vasculitis in Scotland: validation of the Renal Risk Score in a complete national cohort. Kidney International Reports, 8(8), pp. 1648-1656. (doi: 10.1016/j.ekir.2023.05.029) (PMID:37547534) (PMCID:PMC10403670)

RECOVERY Collaborative Group (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 401(10387), pp. 1499-1507. (doi: 10.1016/s0140-6736(23)00510-x) (PMID:37060915) (PMCID:PMC10156147)

Mayne, Kaitlin J., Lees, Jennifer S. ORCID: https://orcid.org/0000-0001-6331-0178, Rutherford, Elaine, Thomson, Peter C., Traynor, Jamie P., Dey, Vishal ORCID: https://orcid.org/0000-0002-5108-4158, Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887 and Mark, Patrick B. ORCID: https://orcid.org/0000-0003-3387-2123 (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16(3), pp. 512-520. (doi: 10.1093/ckj/sfac248) (PMID:36865003) (PMCID:PMC9972818)

RECOVERY Collaborative Group (2023) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 399(10320), pp. 143-151. (doi: 10.1016/s0140-6736(21)01825-0) (PMID:34800427) (PMCID:PMC8598213)

RECOVERY Collaborative Group (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 399(10325), pp. 665-676. (doi: 10.1016/s0140-6736(22)00163-5) (PMID:35151397) (PMCID:PMC8830904)

Aiyegbusi, O. et al. (2021) ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study. RMD Open, 7(2), e001555. (doi: 10.1136/rmdopen-2020-001555) (PMID:33875562) (PMCID:PMC8057563)

Abani, O. et al. (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet, 397(10289), pp. 2049-2059. (doi: 10.1016/S0140-6736(21)00897-7) (PMID:34000257) (PMCID:PMC8121538)

Abani, O. et al. (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10285), pp. 1637-1645. (doi: 10.1016/S0140-6736(21)00676-0) (PMID:33933206) (PMCID:PMC8084355)

RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine, 384(8), pp. 693-704. (doi: 10.1056/nejmoa2021436) (PMID:32678530) (PMCID:PMC7383595)

Abaleke, E. et al. (2021) Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10274), pp. 605-612. (doi: 10.1016/S0140-6736(21)00149-5) (PMID:33545096) (PMCID:PMC7884931)

Kolb, A. et al. (2021) A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney International Reports, 6(2), pp. 449-459. (doi: 10.1016/j.ekir.2020.10.033) (PMID:33615070) (PMCID:PMC7879209)

RECOVERY Collaborative Group (2020) Effect of hydroxychloroquine in hospitalized patients with Covid-19. New England Journal of Medicine, 383(21), pp. 2030-2040. (doi: 10.1056/nejmoa2022926) (PMID:33031652) (PMCID:PMC7556338)

Dey, Vishal ORCID: https://orcid.org/0000-0002-5108-4158, Farrah, Tariq E., Traynor, Jamie P., Spalding, Elaine M., Robertson, Susan E. and Geddes, Colin C. (2017) Symptomatic fracture risk in the renal replacement therapy population. Nephrology Dialysis Transplantation, 32(7), pp. 1211-1216. (doi: 10.1093/ndt/gfw222) (PMID:27257273)

Dey, Vishal, Jones, Audrey and Spalding, Elaine M. (2016) Telehealth: acceptability, clinical interventions and quality of life in peritoneal dialysis. SAGE Open Medicine, 4, pp. 1-6. (doi: 10.1177/2050312116670188) (PMID:27757228) (PMCID:PMC5052928)

Dey, V., Hair, M. and Spalding, E. M. (2015) Thrice weekly nocturnal in-centre haemodiafiltration: a 2-year experience. Nephron, 5, pp. 50-57. (doi: 10.1159/000436982) (PMID:26557842) (PMCID:PMC4592506)